Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease

NCT04116242 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT04116242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04116242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Overall status
Completed
Start date
August 27, 2015
Completion date
June 10, 2024
Enrollment
277 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute-on-chronic liver failure, cirrhosis of the liver, liver disease, liver failure